HTuO Biosciences

CEO Anthony Fejes will attend the JLABS Global CEO Summit in New York City. The three-day forum, held exclusively for JLABS company leaders, connects Johnson & Johnson executives, JPALs, dealmakers, entrepreneurs, and investors. The overarching goal of this exclusive event is to help companies bring their sciences and technologies to patients who need them most. #JLABS #biotech #drugdiscovery 📅 October 21-23, 2024 📍 New York Stock Exchange, New York City

We are very excited to be presenting at the Sweet Biopharma Day 2024.

Our Director of Business Development, Jacek Mis, will attend BIO-Europe in Stockholm, Sweden, next month. You can find him through the partnering portal or email us directly to learn about our physics-based drug discovery technology. #BIOEurope #drugdiscovery #computationalchemistry

#Hiring Scientist: Molecular Modelling & Development (Computational Physicist) We are seeking a talented scientist to join our team. To learn more & apply, go to our website: www.htuobio.com #biotech #physics #drugdiscovery

We are pleased to announce the appointment of seasoned biopharmaceutical development executive Neil Klompas to the board of directors. Learn more here: https://lnkd.in/gKJsXH6v #team

Our team (Ahmed Ayoub & Yi-Hsuan Lin) has arrived in Denver for the American Chemical Society Fall 2024 conference! Along with their bear friend, they will embody strength, courage, and wisdom as they present the elegant science that forms the foundation of HTuO Biosciences’ core technology. #ACSFall2024 #sciences #chemistry #physics #biotech

#HIRING 1) Scientist - Chemoinformatics & Computational Chemistry 2) Scientist - Molecular Modeling & Development We are looking to hire two talented scientists with expertise in chemoinformatics and computational chemistry. Learn more and apply at: https://lnkd.in/gMBX7ZNN #drugdiscovery #biotech #computationalchemistry

Our scientists, Yi-Hsuan Lin and Ahmed Ayoub, will attend the #ACSFall2024 conference from August 18 to 22 in Denver, Colorado. They will present two posters during the Division of Computers in Chemistry Poster Session on Tuesday, August 20th. The posters are: 1. "AtomForge: Advances in the development of a polarizable and reactive force field" (Poster board #468) 2. "AtomForge: A reactive and polarizable force field for multi-scale simulations of small molecules and macromolecules in drug discovery" (Poster board #452).

We're pleased to announce the companies selected to pitch at our upcoming Invest in BC conference presented by Lumira Ventures! This highly anticipated investment event draws trailblazing companies, global investors, and healthcare innovators together for engaging programming, company pitches, and collaboration opportunities. Secure your spot now to take advantage of early bird pricing! Find the list of presenting companies and purchase tickets here: https://lnkd.in/gSjeKqyh #LSBCinvest ARC Medical Inc. Axolotl Biosciences Bold Therapeutics Inc. CereCura Nanotherapeutics Clairvoyant Therapeutics Eyam Vaccines and Immunotherapeutics EyeCare X Fluttercare FMRK Diagnostic Technologies GuideStar Medical Devices HTuO Biosciences IKOMED Technologies Inc. Integrated Nanotherapeutics Inc. Lexaria Bioscience Mesintel Therapeutics Microbion Corporation Pramana Qu Biologics Inc. Rakovina Therapeutics Rehabtronics Response Biomedical Corp. SmartParent Mobile Health Inc. SnapCyte Solutions Inc. Sonic Incytes Medical Corp. Sustained Therapeutics Total Flow Medical Variational AI ViewsML Technologies VoxCell BioInnovation Zymeworks Inc.

The HTuO team had a fantastic 2024 Summer ☀ BBQ to celebrate our upcoming 4-year anniversary. We took a break from work 😎 to enjoy great food 🥗 and each other's company. Despite being a small team, we have achieved a lot to date! #team